Good morning :)
$
₹
Lifevantage Corporation

Lifevantage Corporation

LFVN

NASDAQ
Asset Logo

Lifevantage Corporation

LFVN

NASDAQ
$5.683.07% (-0.18)
$
₹
$5.683.07% (-0.18)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Consumer Defensive

Packaged Foods

Micro Cap

With a market cap of $73.8M the stock is ranked 4851

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

14.65
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.29
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.4
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.36
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

2.78%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

3.09%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 2 analysts reports

Buy
1 analyst
Hold
1 analyst
Sell
0 analyst

Price Upside

+27.99%

Earnings Growth

-42.27%

Rev. Growth

-9.38%

See Detailed Forecast

Company Profile

Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Unilever PLC ADR
UL
Unilever PLC ADR
P/E Ratio
13.37
13.37
1Y Return
7.19%
7.19%
Buy Reco %
60.00
60.00
Estee Lauder Companies Inc
EL
Estee Lauder Companies Inc
P/E Ratio
217.34
217.34
1Y Return
9.22%
9.22%
Buy Reco %
50.00
50.00
Kenvue Inc.
KVUE
Kenvue Inc.
P/E Ratio
22.75
22.75
1Y Return
31.31%
31.31%
Buy Reco %
14.28
14.28
ELF Beauty Inc
ELF
ELF Beauty Inc
P/E Ratio
116.57
116.57
1Y Return
8.62%
8.62%
Buy Reco %
66.66
66.66
Inter Parfums Inc
IPAR
Inter Parfums Inc
P/E Ratio
21.98
21.98
1Y Return
17.55%
17.55%
Buy Reco %
33.33
33.33
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 27.99% growth, versus a trailing 3-year CAGR of -5.84%.

2026
Current$5.86Baseline
Analyst Target - 1 year
Target$7.5+27.99%

All values in $

202220232024202520262027$7.03$11.05$15.07Target+27.99%
2026
Current$5.86Baseline
Analyst Target - 1 year
Target$7.5+27.99%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -9.38% growth, versus a trailing 3-year CAGR of -5.07%.

2026
Current$182.58Baseline
Forecast for Jun 2027
High$171.64-5.99%
Average$165.45-9.38%
Low$160.81-11.92%

All values in $ Million

202220232024202520262027206.36213.39200.16228.53182.58Low-11.92%Average-9.38%High-5.99%
2026
Current$182.58Baseline
Forecast for Jun 2027
High$171.64-5.99%
Average$165.45-9.38%
Low$160.81-11.92%

All values in $ Million

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -42.27% growth, versus a trailing 3-year CAGR of 32.64%.

2026
Current$0.56Baseline
Forecast for Jun 2027
High$0.4-28.57%
Average$0.32-42.27%
Low$0.18-67.86%

All values in $

2022202320242025202620270.410.240.580.80.56Low-67.86%Average-42.27%High-28.57%
2026
Current$0.56Baseline
Forecast for Jun 2027
High$0.4-28.57%
Average$0.32-42.27%
Low$0.18-67.86%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

47.5
2.1
48.9
0.2
43.7
1.3
42.3
1.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue48.2448.9347.2167.7658.4455.1147.5648.9343.7142.37
Net Income1.651.301.822.553.471.952.150.271.361.27
Net Profit Margin3.43%2.66%3.86%3.76%5.93%3.55%4.53%0.56%3.11%3.01%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
Consumer DefensivePackaged Foods

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Lifevantage Corporation 14.652.290.36
Unilever PLC ADR13.377.2910.92
Estee Lauder Companies Inc217.348.922.12
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare LFVN with any stock or ETF
Compare LFVN with any stock or ETF
Comparing from
LFVN
UL
EL
Loading...

Frequently asked questions

  1. Lifevantage Corporation (LFVN) share price today is $5.68 as of October 27, 2026 at 12:18 AM IST. The stock touched a day high of $5.84 and a day low of $5.55.

  2. Lifevantage Corporation stock trades on NASDAQ under the ticker symbol LFVN.

  3. Lifevantage Corporation's market capitalization is $73.77M as of October 27, 2026 at 12:18 AM IST.

  4. Lifevantage Corporation's price-to-earnings (P/E) ratio is 14.65 as of October 26, 2026.

  5. Lifevantage Corporation's price-to-book (P/B) ratio is 2.29 as of October 26, 2026.

  6. Yes, Lifevantage Corporation pays a dividend, with a current dividend yield of 3.09%.

  7. Yes, You can buy Lifevantage Corporation shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Lifevantage Corporation shares in three steps: 1. Search Lifevantage Corporation on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Lifevantage Corporation trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Lifevantage Corporation (LFVN) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 1.7605 shares at the current price of $5.68.

Loading...